{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:45:16Z","timestamp":1773236716999,"version":"3.50.1"},"reference-count":15,"publisher":"American Association for Cancer Research (AACR)","issue":"10","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>About 30% of all colorectal cancers are thought to have a genetic basis and the known predisposing genes can only account for a small fraction of cases. A previous report suggested that a colorectal cancer candidate gene, explaining at least 20% of colorectal cancer cases with family history, was located within a 25 cM region on chromosome 9q22.2-q31.3. We typed 16 polymorphic markers encompassing the region of putative linkage in 57 colorectal tumor families from the United Kingdom. Known Mendelian syndromes had been excluded. We found suggestive evidence of linkage, as positive parametric (HLOD = 1.23) and nonparametric (NPL = 1.21, P = 0.11) LOD scores were obtained by analysis of the whole family set. Enrichment for cases with a priori genetic etiology by analyzing families with at least one person affected at &amp;lt;45 years of age (n = 39 families) gave a maximum multipoint NPL score of 2.65 (P = 0.007). In this group, significant NPL scores &amp;gt;1.67 (P &amp;lt; 0.05) were found in a 6.5 cM region between D9S1851 and D9S277. With a more stringent threshold (NPL&amp;gt;2.4, P &amp;lt; 0.01), the linked region was 1.7 cM between D9S971 and D9S272\/D9S173. Exclusion from the analysis of kindreds with a phenotype of multiple polyposis also found evidence of linkage in the same region (NPL = 2.47 at close to D9S277, P = 0.009). The type I transforming growth factor-\u03b2 receptor, a prime candidate gene, was excluded as a cause of disease. The results presented here further support the existence of a colorectal cancer susceptibility gene on chromosome 9q and refine its likely location. (Cancer Res 2006; 66(10): 5003-6)<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-4074","type":"journal-article","created":{"date-parts":[[2006,5,16]],"date-time":"2006-05-16T22:47:01Z","timestamp":1147819621000},"page":"5003-5006","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Evidence of Linkage to Chromosome 9q22.33 in Colorectal Cancer Kindreds from the United Kingdom"],"prefix":"10.1158","volume":"66","author":[{"given":"Zoe E.","family":"Kemp","sequence":"first","affiliation":[{"name":"1Molecular and Population Genetics Laboratory, Cancer Research UK, London, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis G.","family":"Carvajal-Carmona","sequence":"additional","affiliation":[{"name":"1Molecular and Population Genetics Laboratory, Cancer Research UK, London, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"Barclay","sequence":"additional","affiliation":[{"name":"1Molecular and Population Genetics Laboratory, Cancer Research UK, London, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Gorman","sequence":"additional","affiliation":[{"name":"1Molecular and Population Genetics Laboratory, Cancer Research UK, London, United Kingdom;"},{"name":"2Colorectal Cancer Unit, Cancer Research UK, St Mark's Hospital, Harrow, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Martin","sequence":"additional","affiliation":[{"name":"1Molecular and Population Genetics Laboratory, Cancer Research UK, London, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Wood","sequence":"additional","affiliation":[{"name":"3Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Rowan","sequence":"additional","affiliation":[{"name":"1Molecular and Population Genetics Laboratory, Cancer Research UK, London, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Donohue","sequence":"additional","affiliation":[{"name":"1Molecular and Population Genetics Laboratory, Cancer Research UK, London, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Spain","sequence":"additional","affiliation":[{"name":"1Molecular and Population Genetics Laboratory, Cancer Research UK, London, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Jaeger","sequence":"additional","affiliation":[{"name":"1Molecular and Population Genetics Laboratory, Cancer Research UK, London, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Gareth","family":"Evans","sequence":"additional","affiliation":[{"name":"4University Department of Medical Genetics and Regional Genetics Service, St Mary's Hospital, Central Manchester Healthcare Trust, Manchester, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eamonn R.","family":"Maher","sequence":"additional","affiliation":[{"name":"5Section of Medical and Molecular Genetics, University of Birmingham and West Midlands Regional Genetics Service, Birmingham Women's Hospital, Birmingham, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Bishop","sequence":"additional","affiliation":[{"name":"6Genetic Epidemiology Laboratory, Cancer Research UK, St James' University Hospital, Leeds, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huw","family":"Thomas","sequence":"additional","affiliation":[{"name":"2Colorectal Cancer Unit, Cancer Research UK, St Mark's Hospital, Harrow, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Houlston","sequence":"additional","affiliation":[{"name":"3Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"1Molecular and Population Genetics Laboratory, Cancer Research UK, London, United Kingdom;"},{"name":"2Colorectal Cancer Unit, Cancer Research UK, St Mark's Hospital, Harrow, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"and the Colorectal Tumour Gene Identification Study Consortium","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2006,5,16]]},"reference":[{"key":"2022061621202307100_B1","doi-asserted-by":"crossref","unstructured":"Wiesner GL, Daley D, Lewis S, et al. A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2. Proc Natl Acad Sci U S A\u20082003; 100: 12961\u20135.","DOI":"10.1073\/pnas.2132286100"},{"key":"2022061621202307100_B2","doi-asserted-by":"crossref","unstructured":"Bonaiti-Pellie C. Genetic risk factors in colorectal cancer. Eur J Cancer Prev\u20081999; 8 Suppl 1: S27\u201332.","DOI":"10.1097\/00008469-199912001-00005"},{"key":"2022061621202307100_B3","doi-asserted-by":"crossref","unstructured":"Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med\u20081988; 319: 533\u20137.","DOI":"10.1056\/NEJM198809013190902"},{"key":"2022061621202307100_B4","doi-asserted-by":"crossref","unstructured":"Houlston RS, Collins A, Slack J, Morton NE. Dominant genes for colorectal cancer are not rare. Ann Hum Genet\u20081992; 56: 99\u2013103.","DOI":"10.1111\/j.1469-1809.1992.tb01136.x"},{"key":"2022061621202307100_B5","doi-asserted-by":"crossref","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med\u20082000; 343: 78\u201385.","DOI":"10.1056\/NEJM200007133430201"},{"key":"2022061621202307100_B6","doi-asserted-by":"crossref","unstructured":"O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet\u20081998; 63: 259\u201366.","DOI":"10.1086\/301904"},{"key":"2022061621202307100_B7","unstructured":"Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet\u20081996; 58: 1347\u201363."},{"key":"2022061621202307100_B8","unstructured":"Weeks. Recode: Program to recode raw data into numbered alleles: Pittsburgh (Pennsylvania): University of Pittsburgh; 2001."},{"key":"2022061621202307100_B9","doi-asserted-by":"crossref","unstructured":"de Boer J, Hoeijmakers JH. Cancer from the outside, aging from the inside: mouse models to study the consequences of defective nucleotide excision repair. Biochimie\u20081999; 81: 127\u201337.","DOI":"10.1016\/S0300-9084(99)80045-5"},{"key":"2022061621202307100_B10","unstructured":"Pasche B, Luo Y, Rao PH, et al. Type I transforming growth factor \u03b2 receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res\u20081998; 58: 2727\u201332."},{"key":"2022061621202307100_B11","unstructured":"Pasche B, Kolachana P, Nafa K, et al. T\u03b2R-I(6A) is a candidate tumor susceptibility allele. Cancer Res\u20081999; 59: 5678\u201382."},{"key":"2022061621202307100_B12","doi-asserted-by":"crossref","unstructured":"Bian Y, Caldes T, Wijnen J, et al. TGFBR1*6A may contribute to hereditary colorectal cancer. J Clin Oncol\u20082005; 23: 3074\u20138.","DOI":"10.1200\/JCO.2005.00.281"},{"key":"2022061621202307100_B13","doi-asserted-by":"crossref","unstructured":"Kaklamani VG, Hou N, Bian Y, et al. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies. J Clin Oncol\u20082003; 21: 3236\u201343.","DOI":"10.1200\/JCO.2003.11.524"},{"key":"2022061621202307100_B14","doi-asserted-by":"crossref","unstructured":"Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet\u20082000; 67: 146\u201354.","DOI":"10.1086\/302957"},{"key":"2022061621202307100_B15","doi-asserted-by":"crossref","unstructured":"Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet\u20081995; 11: 241\u20137.","DOI":"10.1038\/ng1195-241"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/10\/5003\/2549658\/5003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/10\/5003\/2549658\/5003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T19:38:26Z","timestamp":1655408306000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/10\/5003\/525717\/Evidence-of-Linkage-to-Chromosome-9q22-33-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,15]]},"references-count":15,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2006,5,16]]},"published-print":{"date-parts":[[2006,5,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-4074","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,15]]}}}